Placental 15-hydroxyprostaglandin dehydrogenase binding site requirements.
D000429:Alcohol Oxidoreductases / Q000378:metabolism*; D001095:Arachidonic Acids / Q000494:pharmacology; D001665:Binding Sites; D005260:Female; D006801:Humans; D006911:Hydroxyprostaglandin Dehydrogenases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D007700:Kinetics; D009243:NAD / Q000378:metabolism; D010920:Placenta / Q000201:enzymology*; D011247:Pregnancy; D011453:Prostaglandins / Q000378:metabolism; D013256:Steroids / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013963:Thyroid Hormones / Q000494:pharmacology
D001095:Arachidonic Acids; D011453:Prostaglandins; D013256:Steroids; D013963:Thyroid Hormones; D009243:NAD; D000429:Alcohol Oxidoreductases; D006911:Hydroxyprostaglandin Dehydrogenases